Location: Home
  • search
  • go
  • Relate News
  • 1/6/2025China Launches Action Plan to Tackle Dementia amid Aging Population Ch...
  • 1/6/2025GSK's Nucala Gains Expanded Approval in China for CRSwNP Treatment
  • 1/6/2025WuXi Bio Divests Irish Vaccine Facility to Merck Amid Potential U.S. R...
  • 1/6/2025I-Mab Reprioritizes Pipeline and Halts CD73 Development
  • 1/3/2025Biocon Wins NMPA Approval for Tacrolimus Capsules in China
  • 1/3/2025China Punishes 40,000 in Medical Corruption Crackdown, Targeting Over ...
  • 1/3/2025China Launches Mini-Programs to Boost Drug Price Transparency
  • 1/3/2025China Strengthens Oversight of Medical Insurance Funds with Traceabili...
  • 1/3/2025China Prioritizes Mental Health with Nationwide Initiative
  • 1/3/2025WuXi Biologics and Sino Biopharm Partner on mAb Discovery
  • 1/3/2025NMPA Issues Annexes for Pharmaceutical Excipients and Packaging Materi...
  • 1/3/2025Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...
  • 1/3/2025Prime Gene Therapeutics Completes Over CNY 300M in Series B Financing
  • 1/3/2025Platinum Life Receives Conditional Approval for China's First Stem Cel...
  • 1/3/2025Recent Official and Executive Moves
  • 1/2/2025Hutchmed Announces $608M Non-core Chinese Unit Stake Sale
  • 12/30/2024TEVIMBRA Approved in the U.S. as First-line Treatment of G/GEJ in Com...
  • 12/30/2024 India Deepens Ties with Chinese Biotech: Cipla and Mankind Lead the W...
  • 12/30/2024TJ Bio Submits BLA for Genexine's Long-Acting Pediatric Growth Hormone...
  • 12/30/20242025 Forecast: What Can AstraZeneca's China Probes Teach Other Biophar...
  • 12/27/2024Review of China's Hospital Drug Market: Strong Competition Amid Slight...
  • 12/27/2024China's Commercial Health Insurance: Growth Trends and Challenges in C...
  • 12/27/2024Collaborative Governance Mechanism for Healthcare, Medical Insurance, ...
  • 12/27/2024Recent Executive Moves
  • 12/26/2024Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...
  • 12/24/2024Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
  • 12/24/2024State Council Moves to Advance Pharma Reforms and Regulatory Streamlin...
  • 12/24/2024WuXi Biologics to Divest Advanced Therapies Unit Amid U.S. Restriction...
  • 12/23/2024Sanofi Acquires Rights to Cytokinetics's Aficamten in Greater China
  • 12/23/2024MSD Finalizes Exclusive Global License Deal for Anti-PD-1 LM-299
  • Page:25/369 Total number of articles:11062: [First][<<] [23] [24] [25] [26] [27] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group